ASCO 2027 exhibitors
Jun 4–8, 2027 Chicago, IL ~44k attendees Website
296 organizations exhibit at ASCO 2027 — 139 diagnostics, technology and service companies, 88 drug developers and 69 advocacy groups, societies, cancer centers, publishers and agencies. 296 of them have their own page in this guide. As of Oct 8, 2026.
Focus
Showing 1–30 of 296 organizations
| Organization | ASCO 2027 Attendance |
|---|---|
1Cell.Ai Cupertino, CA | |
Single-cell multi-omics testing of live circulating tumor cells from blood, with AI models that predict homologous recombination deficiency. | Booth Exhibiting at Booth 24016 |
AbbVie North Chicago, IL | |
Global drugmaker whose cancer medicines include venetoclax and ibrutinib for blood cancers and the ADC mirvetuximab soravtansine for ovarian cancer. | Booth Exhibiting at Booth 27033 |
Accord BioPharma Raleigh, NC | |
Specialty arm of the Intas group marketing the prostate cancer drug Camcevi, lenalidomide, and supportive-care biosimilars such as filgrastim and pegfilgrastim. | Booth Exhibiting at Booth 37073 |
Acrotech Biopharma East Windsor, NJ | |
Specialty drug company commercializing approved cancer medicines in the US, including treatments for T-cell lymphoma. | Booth Exhibiting at Booth 10092 |
Adaptive Biotechnologies Seattle, WA | |
Immune-sequencing company whose clonoSEQ test measures minimal residual disease in myeloma, leukemia and lymphoma. | Booth Exhibiting at Booth 17151 |
Advanced Clinical Deerfield, IL | |
Clinical development partner offering CRO, functional service provider and staffing services from early-phase research to commercialization. | Booth Exhibiting at Booth IH05 |
Advanced CTS Somerset, NJ | |
FDA-registered drug wholesaler providing clinical trial supply services: comparator sourcing, import and export, and drug depot storage. | Booth Exhibiting at Booth 35142 |
Agendia Irvine, CA | |
Breast cancer genomics company whose MammaPrint and BluePrint tests gauge recurrence risk and tumor subtype to guide early-stage treatment. | Booth Exhibiting at Booth 27147 |
Agilent Technologies Santa Clara, CA | |
Laboratory technology company whose clinical offerings include pathology staining systems, PD-L1 companion diagnostics and genomic assays for cancer testing. | Booth Exhibiting at Booth 13149 |
Aignostics Berlin, Germany | |
AI pathology company analyzing tissue images and multimodal data for biopharma, from target discovery to trials and companion diagnostics. | Booth Exhibiting at Booth IH15 |
Akeso Zhongshan City, China | |
Chinese antibody drugmaker with bispecific immunotherapies, including the PD-1/VEGF antibody ivonescimab for lung cancer. | Booth Exhibiting at Booth 37147 |
Allucent Cary, NC | |
Contract research organization running oncology and hematology trials for small and mid-size biopharma, from preclinical work to Phase IV. | Booth Exhibiting at Booth 27036 |
Almac Craigavon, UK | |
Diagnostic services unit of the Almac group, running biomarker and companion diagnostic development, multi-omic analysis and clinical testing for drug trials. | Booth Exhibiting at Booth 15157 |
ALX Oncology South San Francisco, CA | |
Clinical-stage immuno-oncology biotech developing evorpacept, a CD47 blocker, with positive data in HER2-positive gastric cancer. | Booth Exhibiting at Booth IH09 |
American Society of Hematology Washington, DC | |
Professional society of hematologists supporting research, education and advocacy on blood diseases, with meetings, journals and awards. | Booth Exhibiting at Booth 10024 |
Amgen Thousand Oaks, CA | |
Biotechnology drugmaker with cancer medicines for lung, blood and colorectal cancers, including targeted therapies and bispecific T-cell engagers. | Booth Exhibiting at Booth 22025 |
Amoy Diagnostics Xiamen, China | |
Chinese maker of PCR and sequencing kits that detect tumor gene mutations, including companion diagnostics widely used in lung cancer. | Booth Exhibiting at Booth 22114 |
AplusA Lyon, France | |
French healthcare research company that collects real-world prescribing and patient data worldwide and turns it into insights for drugmakers. | Booth Exhibiting at Booth 14156 |
Arcus Biosciences Hayward, CA | |
Clinical-stage biotech with registrational programs in kidney cancer (HIF-2α inhibitor casdatifan) and pancreatic cancer (CD73 inhibitor quemliclustat). | Booth Exhibiting at Booth 32146 |
Arima Genomics Orlando, FL | |
Genomics company whose CLIA lab tests tumors using whole-genome sequencing plus 3D genome structure; also sells research kits and software. | Booth Exhibiting at Booth 10082 |
Ascentage Pharma Suzhou, China | |
Drug developer focused on blood cancers, with the TKI olverembatinib and the Bcl-2 inhibitor lisaftoclax among its programs. | Booth Exhibiting at Booth 37103 |
Astellas Tokyo, Japan | |
Japanese drugmaker with cancer medicines including enzalutamide for prostate cancer, enfortumab vedotin for bladder cancer and zolbetuximab for gastric cancer. | Booth Exhibiting at Booth 15117 |
AstraZeneca Cambridge, UK | |
Global drugmaker with cancer medicines across lung, breast, blood and other cancers, including targeted therapies, immunotherapy and ADCs. | Booth Exhibiting at Booth 19029 |
AVEO Oncology Boston, MA | |
Oncology company, owned by LG Chem, that markets the kidney cancer drug tivozanib (Fotivda) in the US. | Booth Exhibiting at Booth 19023 |
Bayer Leverkusen, Germany | |
Global drugmaker whose cancer medicines include darolutamide and radium-223 for prostate cancer and regorafenib for colorectal and liver cancers. | Booth Exhibiting at Booth 13059 |
BeOne Medicines Basel, Switzerland | |
Global oncology company, formerly BeiGene, marketing zanubrutinib for blood cancers and the PD-1 antibody tislelizumab. | Booth Exhibiting at Booth 24021, 24033 |
BillionToOne Northstar Menlo Park, CA | |
Oncology testing arm of BillionToOne, using single-molecule counting NGS for liquid biopsy therapy selection and treatment response monitoring. | Booth Exhibiting at Booth 10071 |
Biocartis Mechelen, Belgium | |
Maker of the Idylla automated PCR system for rapid molecular testing of tumor samples to guide treatment. | Booth Exhibiting at Booth 37075 |
Biodesix Louisville, CO | |
Diagnostics company with blood-based lung cancer tests, plus development services for biopharma diagnostic and drug programs. | Booth Exhibiting at Booth 30099 |
BioNTech Mainz, Germany | |
Immunotherapy company developing mRNA cancer vaccines, a PD-L1/VEGF bispecific antibody, antibody-drug conjugates and CAR-T cell therapies. | Booth Exhibiting at Booth 24103 |
Instantly find 20 buyers from ASCO 2027 exhibitors
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse ASCO 2027 by
Organization type
Focus
- Clinical trials 58
- Biomarkers and genomics 44
- AI and data 38
- Blood cancers 36
- Lung cancer 28
- Genitourinary cancers 24
- Gastrointestinal cancers 21
- Breast cancer 18
- Immunotherapy 17
- Imaging and radiation 17
- Patient support and survivorship 14
- Antibody-drug conjugates 9
- Cell and gene therapy 8
- Melanoma and skin cancers 7
- Gynecologic cancers 6
Exhibit hall
- Exhibitors 296
Everyone
Not affiliated with the American Society of Clinical Oncology. Organization details are derived from ASCO’s published exhibitor list and each exhibitor’s own profile and website. Submit a correction